Share buyback fuels Aarti Drugs rally, stock jumps 13%

Shares of Aarti Drugs on Thursday jumped 13% on BSE to its day’s high of Rs 601.20 after the company on Wednesday announced its plans to consider a share buyback in its upcoming board meeting on August 26.

“This is to inform you that the next Meeting of the Board of Directors of the Company is scheduled to be held on Monday, August 26, 2024, to consider the proposal of buyback of the fully paid-up equity shares of Rs. 10/- each of the Company including matters related/incidental thereto,” said the company in its filing to the stock exchanges.

Prior to this, the company carried out a share buyback 5 times since 2016, according to the data available on Trendlyne.


In the last one year, the stock has been trading flat with a positive bias, up by merely 0.26%, while on a year-to-date basis, the stock has gained approximately 16%. In the last 1 month, the shares of Aarti Drugs have gained 10%.

Also read: Hot stocks: Brokerage view on Shyam Metalics, IndiGo, Vedanta, Zomato and Paytm

Technically, the stock is well placed on charts above all its significant short, medium and long-term exponential moving averages and is oscillating near the mid-range mark of 60 on the RSI, according to the Trendlyne data.

Aarti Drugs is a pharmaceutical company established in 1984 and is a part of the Aarti Group of Industries, which has a robust R&D Division located in Tarapur. The company has been actively involved in the pharmaceutical sector and is known for its products and growth in the market.

The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, specialty chemicals and also produces formulations with its wholly-owned subsidiary – Pinnacle Life Science.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)